Terumo Corp
TSE:4543
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2 129.2177
3 160
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Terumo Corp
Common Shares Outstanding
Terumo Corp
Common Shares Outstanding Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Terumo Corp
TSE:4543
|
Common Shares Outstanding
ÂĄ1.5B
|
CAGR 3-Years
25%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
||
Olympus Corp
TSE:7733
|
Common Shares Outstanding
ÂĄ1.2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-2%
|
||
Sysmex Corp
TSE:6869
|
Common Shares Outstanding
ÂĄ623.5m
|
CAGR 3-Years
44%
|
CAGR 5-Years
24%
|
CAGR 10-Years
12%
|
||
Nihon Kohden Corp
TSE:6849
|
Common Shares Outstanding
ÂĄ167.8m
|
CAGR 3-Years
26%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
||
JEOL Ltd
TSE:6951
|
Common Shares Outstanding
ÂĄ51.1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
||
Fukuda Denshi Co Ltd
TSE:6960
|
Common Shares Outstanding
ÂĄ28.8m
|
CAGR 3-Years
24%
|
CAGR 5-Years
14%
|
CAGR 10-Years
7%
|
Terumo Corp
Glance View
Terumo Corporation, founded in 1921 and headquartered in Tokyo, Japan, has carved a significant niche in the global healthcare landscape as a leader in medical technology. With a steadfast commitment to enhancing the quality of life, Terumo focuses on innovative solutions in areas such as blood management, cardiovascular interventions, and surgical devices. Through a history of groundbreaking research and development, Terumo has established a robust portfolio of products that not only meet immediate clinical needs but also pave the way for advancements in patient care. The company’s dedication to sustainability and social responsibility further solidifies its reputation as a trustworthy and forward-thinking organization committed to making a positive impact on society. For investors, Terumo presents an attractive opportunity characterized by steady growth, a diverse global presence, and a solid financial foundation. The company's strategic focus on expanding its international footprint, particularly in emerging markets, positions it to capitalize on the rising demand for healthcare innovations. With an increasingly aging population and a growing emphasis on preventative care and advanced treatments, Terumo's comprehensive array of products is well-placed to address these market dynamics. As it continues to invest in R&D and forge strategic partnerships, Terumo Corporation not only stands as a resilient player in the medical technology sector but also as a company poised for long-term growth and value creation for its shareholders.
See Also
What is Terumo Corp's Common Shares Outstanding?
Common Shares Outstanding
1.5B
JPY
Based on the financial report for Sep 30, 2024, Terumo Corp's Common Shares Outstanding amounts to 1.5B JPY.
What is Terumo Corp's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
7%
Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for Terumo Corp have been 25% over the past three years , 15% over the past five years , and 7% over the past ten years .